InxMed

Nanjing, China · In IPO Registration

Developer of cancer therapeutics designed to treat cancer. InxMed is based in Nanjing, China. Its last reported valuation was $306 million in Aug 2025. It has raised $132 million.

Last reported valuation

$306.0M

Oct 2026

Priced at

—

Total raised

$131.6M

Last round

—

How much has InxMed raised?

$131.6Macross 0 recorded rounds

Free account

More of InxMed with a free account

·The complete investor list: 11 names
·Watch InxMed: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

InxMed investors

11 investors are on record for InxMed, including CMG SDIC Fund, Proxima Ventures (China), Ennovation Ventures and Shaaxi Shantou Capital.

For fundraisers

Raising for a company like InxMed?

11 investors have backed InxMed.

See all 11 investors →

Frequently asked about InxMed

How much has InxMed raised?: InxMed has raised $131.6M in total across 0 recorded funding rounds.